Good morning :)
Switch to

Ajanta Pharma Ltd

AJANTPHARM
Health CarePharmaceuticals
MidcapWith a market cap of ₹12,394 cr, stock is ranked 196
Low RiskStock is 1.28x as volatile as Nifty
1,420.3523.40 (-1.62%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Insufficient data

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Stock has been generating better return on equity than bank FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Stock doesn't offer attractive dividend returns

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

Good time to consider, as stock is not in overbought zone

No Red Flags
ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list, with high pledged promoter holding or high default probability should be handled with caution

Stock not in ASM/GSM lists, not a lot of promoter holding is pledged and default probability is low

Health CarePharmaceuticals
MidcapWith a market cap of ₹12,394 cr, stock is ranked 196
Low RiskStock is 1.28x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
26.63
PB RatioPB Ratio
4.81
Dividend YieldDiv. Yield
0.91%
Sector PESector PE
33.78
Sector PBSector PB
3.53
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

75%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20172018201920202.002.142.072.680.500.460.380.46
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered good

83.81% of all the companies listed on NSE have lower pledged promoter holding than the company

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Copy of Newspaper Publication 
Announced OnJul 2, 2020

Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers regarding e-voting information for the 41st Annual General Meeting of the Company in terms of Section 108 of the Companies Act, 2013 read with Rule 20 of Companies (Management and Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in the following newspapers on 2nd July 2020:1. Mumbai edition of Economic Times;2. Mumbai edition of Navshakti.Please take in on your record. | Download

Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers regarding e-voting information for the 41st Annual General Meeting of the Company in terms of Section 108 of the Companies Act, 2013 read with Rule 20 of Companies (Management and Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in the following newspapers on 2nd July 2020:1. Mumbai edition of Economic Times;2. Mumbai edition of Navshakti.Please take in on your record. | Download

Copy of Newspaper Publication 
Announced OnJun 30, 2020

Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers in terms of Circular No. 20/2020 dated 5th May 2020 issued by Ministry of Corporate Affairs, inter-alia, intimating that 41st Annual General Meeting of the Company will be held on 30th July 2020 through Video Conferencing/Other Audio Visual Means, in the following newspapers on 30th June 2020:1. Mumbai edition of Economic Times;2. Mumbai edition of Navshakti.Please take in on your record. | Download

Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers in terms of Circular No. 20/2020 dated 5th May 2020 issued by Ministry of Corporate Affairs, inter-alia, intimating that 41st Annual General Meeting of the Company will be held on 30th July 2020 through Video Conferencing/Other Audio Visual Means, in the following newspapers on 30th June 2020:1. Mumbai edition of Economic Times;2. Mumbai edition of Navshakti.Please take in on your record. | Download

Cash Dividend 
Ex. DateNov 15, 2019

Interim • Div/Share: ₹ 13

See all events